This study examines a very small group of patients with a specific type of lung cancer. The participants were two individuals diagnosed with limited-stage small cell lung cancer who experienced a limited metastatic relapse after completing their initial chemotherapy, radiation, and durvalumab consolidation. Following this relapse, the medical team administered salvage radiotherapy to specific areas, including the adrenal glands and brain lesions, while continuing immunotherapy.
The main finding was that both patients achieved durable disease control. They remained stable for a period exceeding four years after receiving this combination of treatments. No adverse events or serious safety concerns were reported for these two patients during the follow-up period. The study notes that the optimal strategies for treating recurrence after immunotherapy remain unclear.
Readers should understand that this evidence is limited because it is based on only two cases. While the results suggest that curative-intent local radiotherapy may be feasible for carefully selected patients, this finding warrants prospective evaluation in larger studies. This report should not be taken as proof that this treatment will work for all patients with similar conditions.